Global Cancer Gene Therapy Market : Industry Analysis and Forecast (2020-2026) – By Therapy, End User and Region.

Global Cancer Gene Therapy Market was valued at US$ 550.6Mn in 2019 and is expected to reach US$ 3640.3Mn by 2026, at a CAGR of 26.63 % during a forecast period. Cancer gene therapy is a method of treating cancer disease by changing the genetic instructions within an individual’s cells. It is used as a substitute for drugs and surgeries to treat cancer because of the high success rate achieved by trials. Global Cancer Gene Therapy Market To Know About The Research Methodology :- Request Free Sample Report

Global Cancer Gene Therapy Market Dynamics:

Cancer disease occurs because of disrupting the normal cell proliferation and apoptosis process. The advancement in cancer therapy requiresa novel therapeutic agent with a mode of action, mechanisms of cell death and interaction with conventional management. The gene therapy approacheswere developed for the management of cancer, which includesanti-angiogenic gene therapy, pro-apoptotic gene therapy and gene directed-enzyme prodrug therapy. High prevalence of cancer, government initiatives, continuous research & development in the production of cancer gene therapy products, and collaborations to develop gene-therapy products are some of the prominent driving factors behind the global cancer gene therapy market growth. By 2019, greater than 3000 clinical trials were conducted across the globe. Among these trials, greater than 70% are associated with cancer. According to the updated Globocan 2020 estimation, the global cancer burden is indicating that it has risen to 19.3 million cases and more than 10 million cancer deaths in 2020. On the other hand, thehigh cost of gene therapy treatment, annoying immune responses, and risk allied with the treatment are expected to limit the global cancer gene therapy market growth during the forecast period. The Liability of Cancer Worldwide: Cancer is one of the leading causes of death worldwide. In 2019, there were XX.1 million new cases and XX million cancer-related deaths worldwide. By 2026, the number of new cancer cases is expected to grow to more than 20 million. Global Cancer Gene Therapy Market1 The hospital segment is expected to grow at an XX% rate of CAGR during the forecast period. The demand for cancer disease treatment is increasing at an exponential rate. The hospital segment is responding to life-threatening emergencies and many routine health problems that nevertheless require prompt action. High demand for multi-speciality treatment and devices and consumer preference towards innovative surgical procedures performed in hospitals is expected to drive the market growth during the forecast period. North America is supposed to lead the global cancer gene therapy market. North America has dominated the global cancer gene therapy market in 2019. The trend is projected to continue its dominance in the near future because of the growth in the geriatric populations, the presence of well-established healthcare infrastructure for the treatment of cancer and technological developments in the gemmotherapy segment. Also, improvedregulatory standards regarding the quality of products, which are used in gene therapy, high investment in R&D activities, adoption of DNA vaccines and acceptance of the gene therapy treatments are some of the driving factors of the regional market growth. Cancer death in 2019 in the United States: In 2020, 1,806,590 new cases of cancer have diagnosed in the United States In 2019, there were more than 16.9 million cancer survivors in the United States. The number of cancer survivors is expected to increase to 19.2 million by 2026. Asia Pacific is also expected to grow at an XX% rate of CAGR during the forecast period. The presence of the geriatric population is one of the key drivers in the global market. An increase inthe prevalence of cancer, innovation and development in cancer gene therapy are expected to enhance the market regional market growth by 2026. A number of new cancer cases in 2020 In India: Global Cancer Gene Therapy Market2 The objective of the report is to present a comprehensive analysis of the Global Cancer Gene Therapy Marketincluding all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Cancer Gene Therapy Market dynamics, structure by analyzing the market segments and projects the Global Cancer Gene Therapy Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Cancer Gene Therapy Market make the report investor’s guide.

Scope of the Global Cancer Gene Therapy Market: Inquire before buying

Global Cancer Gene Therapy Market3

Global Cancer Gene Therapy Market, by Therapy

• Gene Induced Immunotherapy o Delivery of Cytokines Gene o Delivery of Tumor Antigen Gene • OncolyticVirotherapy o Adenovirus o Lentivirus o Retro Virus o Adeno Associated Virus o Herpes Simplex Virus o Alpha Virus o Vaccinia Virus o Simian Virus o Others • Gene Transfer o Naked/Plasmid Vectors o Electroporation o Sonoportion o Magnetofection o Gene Gun

Global Cancer Gene Therapy Market, by End User

• Hospitals • Diagnostics Centers • Research Institutes

Global Cancer Gene Therapy Market, by Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Global Cancer Gene Therapy Market Key Players

• Shenzhen SibionoGenetech • Adaptimmune • Glaxosmithkline • Oncogenex Pharmaceuticals • Bluebird Bio, Inc. • Synergene Therapeutics • Shanghai Sunway Biotech • Biocancell • Celgene • Merck • ZioPharm Oncology • MolMed • bluebird bio • MultiVir • Adaptimmune Therapeutics plc • Amgen Inc

Global Cancer Gene Therapy Market

1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Cancer Gene Therapy Market Size, by Market Value(US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Cancer Gene Therapy Market 3.4. Geographical Snapshot of the Cancer Gene Therapy Market, By Manufacturer share 4. Global Cancer Gene Therapy Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Sizes 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Cancer Gene Therapy Market 5. Supply Side and Demand Side Indicators 6. Global Cancer Gene Therapy Market Analysis and Forecast, 2019-2026 6.1. Global Cancer Gene Therapy Market Size & Y-o-Y Growth Analysis. 7. Global Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 7.1.1. Gene Induced Immunotherapy 7.1.1.1. Delivery of Cytokines Gene 7.1.1.2. Delivery of Tumor Antigen Gene 7.1.2. OncolyticVirotherapy 7.1.2.1. Adenovirus 7.1.2.2. Lentivirus 7.1.2.3. Retro Virus 7.1.2.4. Adeno Associated Virus 7.1.2.5. Herpes Simplex Virus 7.1.2.6. Alpha Virus 7.1.2.7. Vaccinia Virus 7.1.2.8. Simian Virus 7.1.2.9. Others 7.1.3. Gene Transfer 7.1.3.1. Naked/Plasmid Vectors 7.1.3.2. Electroporation 7.1.3.3. Sonoportion 7.1.3.4. Magnetofection 7.1.3.5. Gene Gun 7.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 7.2.1. Hospitals 7.2.2. Diagnostics Centers 7.2.3. Research Institutes 8. Global Cancer Gene Therapy Market Analysis and Forecasts, By Region 8.1. Market Size (Mn) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 9.1.1. Gene Induced Immunotherapy 9.1.1.1. Delivery of Cytokines Gene 9.1.1.2. Delivery of Tumor Antigen Gene 9.1.2. OncolyticVirotherapy 9.1.2.1. Adenovirus 9.1.2.2. Lentivirus 9.1.2.3. Retro Virus 9.1.2.4. Adeno Associated Virus 9.1.2.5. Herpes Simplex Virus 9.1.2.6. Alpha Virus 9.1.2.7. Vaccinia Virus 9.1.2.8. Simian Virus 9.1.2.9. Others 9.1.3. Gene Transfer 9.1.3.1. Naked/Plasmid Vectors 9.1.3.2. Electroporation 9.1.3.3. Sonoportion 9.1.3.4. Magnetofection 9.1.3.5. Gene Gun 9.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 9.2.1. Hospitals 9.2.2. Diagnostics Centers 9.2.3. Research Institutes 10. North America Cancer Gene Therapy Market Analysis and Forecasts, By Country 10.1. Market Size (Mn) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 11.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 12. Canada Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 12.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 13. Mexico Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 13.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 14. Europe Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 14.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 15. Europe Cancer Gene Therapy Market Analysis and Forecasts, By Country 15.1. Market Size (Mn) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 16.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 17. France Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 17.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 18. Germany Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 18.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 19. Italy Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 19.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 20. Spain Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 20.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 21. Sweden Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 21.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 22. CIS CountriesCancer Gene Therapy Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 22.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 23. Rest of Europe Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 23.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 24. Asia Pacific Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 24.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 25. Asia Pacific Cancer Gene Therapy Market Analysis and Forecasts, by Country 25.1. Market Size (Mn) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 26.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 27. India Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 27.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 28. Japan Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 28.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 29. South Korea Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 29.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 30. Australia Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 30.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 31. ASEAN Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 31.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 32. Rest of Asia Pacific Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 32.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 33. Middle East Africa Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 33.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 34. Middle East Africa Cancer Gene Therapy Market Analysis and Forecasts, by Country 34.1. Market Size (Mn) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 35.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 36. GCC Countries Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 36.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 37. Egypt Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 37.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 38. Nigeria Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 38.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 39. Rest of ME&A Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 39.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 40. South AmericaCancer Gene Therapy Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 40.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 41. South America Cancer Gene Therapy Market Analysis and Forecasts, by Country 41.1. Market Size (Mn) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 42.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 43. Argentina Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 43.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 44. Rest of South America Cancer Gene Therapy Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Mn) Estimates & Forecast By Material Type, 2019-2026 44.2. Market Size (Mn) Estimates & Forecast By End User, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Cancer Gene Therapy Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of key players by price, presence, market share, End Users and R&D investment 45.2.2. New Size Launches and Size Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and End Users 45.2.3.2. M&A Key Players, Forward Integration and Backward Integration 45.3. Company Profile - Key Players 45.3.1. Shenzhen SibionoGenetech 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Size Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Glaxosmithkline 45.3.3. Oncogenex Pharmaceuticals 45.3.4. Bluebird Bio, Inc. 45.3.5. Synergene Therapeutics 45.3.6. Shanghai Sunway Biotech 45.3.7. Biocancell 45.3.8. Celgene 45.3.9. Merck 45.3.10. ZioPharm Oncology 45.3.11. MolMed 45.3.12. bluebird bio 45.3.13. MultiVir 45.3.14. Adaptimmune Therapeutics plc 45.3.15. Amgen Inc

About This Report

Report ID 520
Category Healthcare
Published Date Sep 2019
Updated Date April 2021
Contact Us